Survival Effects of Postmastectomy Adjuvant Radiation Therapy Using Biologically Equivalent Doses: A Clinical Perspective
Open Access
- 4 January 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 98 (1), 26-38
- https://doi.org/10.1093/jnci/djj002
Abstract
Background: Postmastectomy radiation therapy reduces locoregional recurrence among women with operable breast cancer, but whether it improves survival has been controversial. We reanalyzed the results from 36 unconfounded trials (i.e., addition of radiation therapy was the sole discriminant between treatments being compared) that were identified in previous meta-analyses, which provided 38 comparisons. Methods: We used three predefined treatment categories for individual patient data: 1) a biologically equivalent dose (BED) of 40–60 Gy in 2-Gy fractions with an appropriate target volume, 2) an inadequate or excessive dose of radiation therapy, and 3) an inappropriate target volume. Effects of radiation therapy on 5-year and 10-year survival in each of the treatment categories were estimated from a cohort of 13 199 patients from the published rates or, if these were unavailable, from the published survival curves. We also used this categorization to reanalyze data from Early Breast Cancer Trialists' Collaborative Group (EBCTCG) postmastectomy studies. At 10 years, 16 (84%) of the 19 comparisons in our study coincided with those reported by the EBCTCG. All statistical tests were two-sided. Results: Twenty-five of the 38 available comparisons had used optimal and complete radiotherapy (i.e., category 1). Of these 25 comparisons, 17 had 5-year data, and these data showed that adjuvant radiation therapy was associated with a 2.9% absolute increase in survival (odds ratio [OR] of death = 0.87, 95% confidence interval [CI] = 0.79 to 0.96; P = .006). Thirteen category 1 trials had data at 10 years, and these data showed that adjuvant radiation therapy was associated with a statistically significant 6.4% absolute increase in survival (OR of death = 0.78, 95% CI = 0.70 to 0.85; P <.001). No statistically significant change in survival was observed among category 2 (OR of death = 0.91, 95% CI = 0.75 to 1.11) or 3 (OR of death = 0.97, 95% CI = 0.61 to 1.55) trials. Among the 33 EBCTCG studies, odds of local recurrence were reduced more among category 1 trials (80% lower) than among category 2 (70% lower) or 3 (64% lower) trials ( Pheterogeneity <.001). Odds of all-cause death were also lower among category 1 trials (13% lower) than among category 2 (3% lower) or 3 (26% higher) trials ( Pheterogeneity = .01). Conclusions: Adjuvant radiation therapy with an optimal BED and target volume was statistically significantly associated with improved survival for up to 10 years.Keywords
This publication has 51 references indexed in Scilit:
- Risk of Cardiac Death After Adjuvant Radiotherapy for Breast CancerJNCI Journal of the National Cancer Institute, 2005
- Radiotherapy for Breast CancerJNCI Journal of the National Cancer Institute, 2005
- Cardiac morbidity of post-operative adjuvant radiotherapy for breast cancer. A reviewAustralasian Radiology, 1994
- Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) trialEuropean Journal of Cancer, 1992
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- Post-mastectomy megavoltage radiotherapy: The Oslo and Stockholm trialsEuropean Journal of Cancer, 1992
- A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancerBreast Cancer Research and Treatment, 1991
- Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without RadiationNew England Journal of Medicine, 1985
- A clinical trial in the management of operable cancer of the breastBritish Journal of Surgery, 1980
- TREATMENT OF EARLY BREAST CANCERThe Lancet, 1978